221 related articles for article (PubMed ID: 26397898)
1. Methylene Blue Partially Rescues Heart Defects in a Drosophila Model of Huntington's Disease.
Heidari R; Monnier V; Martin E; Tricoire H
J Huntingtons Dis; 2015; 4(2):173-86. PubMed ID: 26397898
[TBL] [Abstract][Full Text] [Related]
2. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
Besson MT; Dupont P; Fridell YW; Liévens JC
Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
Sontag EM; Lotz GP; Agrawal N; Tran A; Aron R; Yang G; Necula M; Lau A; Finkbeiner S; Glabe C; Marsh JL; Muchowski PJ; Thompson LM
J Neurosci; 2012 Aug; 32(32):11109-19. PubMed ID: 22875942
[TBL] [Abstract][Full Text] [Related]
5. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
[TBL] [Abstract][Full Text] [Related]
6. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
7. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
[TBL] [Abstract][Full Text] [Related]
8. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a
Davis GH; Zaya A; Pearce MMP
J Neurosci; 2024 May; 44(20):. PubMed ID: 38589228
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
[TBL] [Abstract][Full Text] [Related]
10. Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila.
Campesan S; Del Popolo I; Marcou K; Straatman-Iwanowska A; Repici M; Boytcheva KV; Cotton VE; Allcock N; Rosato E; Kyriacou CP; Giorgini F
Neurobiol Dis; 2023 Sep; 185():106236. PubMed ID: 37495179
[TBL] [Abstract][Full Text] [Related]
11. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
12. Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila.
Dupont P; Besson MT; Devaux J; Liévens JC
Neurobiol Dis; 2012 Aug; 47(2):237-47. PubMed ID: 22531500
[TBL] [Abstract][Full Text] [Related]
13. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
14. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model.
Zhang S; Feany MB; Saraswati S; Littleton JT; Perrimon N
Dis Model Mech; 2009; 2(5-6):247-66. PubMed ID: 19380309
[TBL] [Abstract][Full Text] [Related]
16. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
17. Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.
Song H; Li H; Guo S; Pan Y; Fu Y; Zhou Z; Li Z; Wen X; Sun X; He B; Gu H; Zhao Q; Wang C; An P; Luo S; Hu Y; Xie X; Lu B
Brain; 2018 Jun; 141(6):1782-1798. PubMed ID: 29608652
[TBL] [Abstract][Full Text] [Related]
18. Rab8 Promotes Mutant HTT Aggregation, Reduces Neurodegeneration, and Ameliorates Behavioural Alterations in a Drosophila Model of Huntington's Disease.
Delfino L; Mason RP; Kyriacou CP; Giorgini F; Rosato E
J Huntingtons Dis; 2020; 9(3):253-263. PubMed ID: 33044189
[TBL] [Abstract][Full Text] [Related]
19. Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors.
Gangwani MR; Soto JS; Jami-Alahmadi Y; Tiwari S; Kawaguchi R; Wohlschlegel JA; Khakh BS
Cell Rep; 2023 Jan; 42(1):111953. PubMed ID: 36640336
[TBL] [Abstract][Full Text] [Related]
20. Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington's Disease Models.
Pruccoli L; Breda C; Teti G; Falconi M; Giorgini F; Tarozzi A
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
